Targeted alpha anticancer therapies: update and future prospects
Barry J Allen,1,2 Chen-Yu Huang,3 Raymond A Clarke2 1Faculty of Physics, University of Sydney, Sydney, NSW, Australia; 2Faculty of Medicine, Ingham Institute, University of Western Sydney, Liverpool, NSW, Australia; 3Central Clinical School, University of Sydney, Sydney, NSW, AustraliaAbstract: Tar...
Guardado en:
Autores principales: | Allen BJ, Huang CY, Clarke RA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e454f40cb7b41de9c24a7b890990185 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current applications and future prospects of nanomaterials in tumor therapy
por: Huang Y, et al.
Publicado: (2017) -
Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug
por: Wang H, et al.
Publicado: (2014) -
Ultrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrug
por: Lin CY, et al.
Publicado: (2012) -
Update on sepsis-associated acute kidney injury: emerging targeted therapies
por: Doyle JF, et al.
Publicado: (2016) -
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Irina Petrache, et al.
Publicado: (2009)